All In Biotech

Drug Trial Radar · NCT04470128

A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy

A Multi-center, Randomized, Two-stage, Phase II Clinical Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Diagnostic or Therapeutic Colonoscopy

Last checked: Nov 20, 2026Latest source record: Feb 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

180

Actual

Start

Aug 19, 2020

Primary completion

Dec 28, 2020

Study completion Jan 30, 2021

Sponsor

Sponsor type
Industry
First posted
Jul 14, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, two-stage, phase II clinical study .The main objective is to evaluate the safety and tolerability of HSK21542 injection for analgesia in patients undergoing colonoscopy, and, combining the pharmacodynamic (PD) and pharmacokinetic (PK) characteristics

Conditions

  • Analgesia

Interventions

  • Stage I: HSK21542 0.5 μg/kgDrug

    intravenous injection

  • Stage I: HSK21542 1 μg/kgDrug

    intravenous injection

  • HSK21542 0.5 μg/kgDrug

    intravenous injection

  • HSK21542 1 μg/kgDrug

    intravenous injection

  • HSK21542 2 μg/kgDrug

    intravenous injection

  • PlaceboDrug

    intravenous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. BPS-NI score>3 did not reach the proportionTime frame: From administration until 24 hours after administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • West China Hospital of Sichuan University

    Chengdu, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.